Oncology Institute, Inc. (TOI) Stock Statistics & Valuation Metrics

Oncology Institute, Inc. has a market cap or net worth of $285.42M. The enterprise value is $274.09M.

Oncology Institute, Inc. has 89,194,115 shares outstanding. The number of shares has decreased by -2.65% in one year.

Oncology Institute, Inc.’s return on equity (ROE) is -18.02 and return on invested capital (ROIC) is -44.83%.

The current PE Ratio of Oncology Institute, Inc. is -0.36. Oncology Institute, Inc.’s PEG ratio is -0.36.

In the last 12 months, Oncology Institute, Inc. had revenue of 393.41M and earned -64.66M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -15.64M and capital expenditures -3.51M, giving a free cash flow of -19.15M billion.

Oncology Institute, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Oncology Institute, Inc. upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.

Oncology Institute, Inc. as a current ratio of 2.15, with Debt / Equity ratio of 560.51%

In the past 12 months, Oncology Institute, Inc. has paid 0.00 in taxes.

Oncology Institute, Inc. EV to EBITDA ratio is -1.90, with an EV/FCF ratio of -3.19.

Oncology Institute, Inc. has $39.74M in cash and marketable securities with $102.31M in debt, giving a net cash position of $62.57M billion.

Gross margin is 10.42%, with operating margin of -15.28%, and net profit margin of -16.44%.

The average price target for Oncology Institute, Inc. is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy